Calcium/Calmodulin‐Dependent Protein Kinase II Inhibitors Mitigate High‐Fat Diet–Induced Obesity in Mice
Journal of Obesity · 2025
DOI: 10.1155/jobe/5530467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obesity, 2025. Verfasst von Naoyuki Kawao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Regenerative Medicine, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan. Hauptthemen laut MEDLINE: Diet, High-Fat, Obesity, Calcium-Calmodulin-Dependent Protein Kinase Type 2, Benzylamines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Salt Science Research Foundation, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Calcium signaling contributes to obesity and its related disorders, such as diabetes. We herein investigated the effects of calcium/calmodulin‐dependent protein kinase II (CaMKII) inhibitors on diet‐induced obesity in mice. In mice fed a high‐fat diet (HFD), the administration of the CaMKII inhibitor KN‐93 and the glycolipid acremomannolipin A with the suppression of CaMKII phosphorylation reduced fat mass in the whole body, epididymal and subcutaneous white adipose tissue weights, and lipid accumulation in epididymal and subcutaneous white adipose tissues, but not muscle mass or bone mineral density at the tibia. Moreover, the administration of KN‐93 and acremomannolipin A improved glucose intolerance in HFD‐fed mice. In an in vitro study on preadipocytic 3T3‐L1 cells and mouse adipose tissue‐derived stromal cells, KN‐93 and acremomannolipin A suppressed adipogenic differentiation, proliferation, and lipid accumulation. In conclusion, this is the first study to demonstrate that CaMKII inhibitors mitigated the development of diet‐induced obesity in mice partly through the suppression of adipogenic differentiation, cell proliferation, and lipid accumulation in adipocytes. Inhibiting CaMKII could be a potential strategy for obesity treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Regenerative Medicine, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
- Laboratory of Molecular Pharmacogenomics, Department of Pharmaceutical Sciences, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Osaka, Japan.
- Life Science Research Institute, Kindai University, Osakasayama, Osaka, Japan.
- Laboratory of Organic Chemistry, Department of Pharmacy, Faculty of Pharmacy, Kindai University, Higashi-Osaka, Osaka, Japan.
- Pharmaceutical Research and Technology Institute, Kindai University, Higashi-Osaka, Osaka, Japan.
ORCID-Profile: Reiko Sugiura, Hiroshi Kaji
Förderung
- Salt Science Research Foundation
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Kawao, N., Satoh, R., Mizukami, Y., Okumoto, K., Tanabe, G., Muraoka, O., Sugiura, R., & Kaji, H. (2025). Calcium/Calmodulin‐Dependent Protein Kinase II Inhibitors Mitigate High‐Fat Diet–Induced Obesity in Mice. Journal of Obesity. https://doi.org/10.1155/jobe/5530467
Vancouver
Kawao N, Satoh R, Mizukami Y, Okumoto K, Tanabe G, Muraoka O, et al. Calcium/Calmodulin‐Dependent Protein Kinase II Inhibitors Mitigate High‐Fat Diet–Induced Obesity in Mice. Journal of Obesity. 2025. doi:10.1155/jobe/5530467
BibTeX
@article{Kawao2025,
author = {Kawao, Naoyuki and Satoh, Ryosuke and Mizukami, Yuya and Okumoto, Katsumi and Tanabe, Genzoh and Muraoka, Osamu and Sugiura, Reiko and Kaji, Hiroshi},
title = {Calcium/Calmodulin‐Dependent Protein Kinase II Inhibitors Mitigate High‐Fat Diet–Induced Obesity in Mice},
journal = {Journal of Obesity},
year = {2025},
doi = {10.1155/jobe/5530467}
}
EUVIMED